Introduction . Acinetobacter infections impose a significant clinical burden, affecting various body systems, including lungs, bloodstream, and urinary tract1. The severity of these infections ranges from mild to acute, with immunocompromised individuals being most susceptible. The emergence of antibiotic-resistant strains, especially of the species A. baumannii , has significantly limited treatment options, necessitating the exploration of alternative therapeutic approaches, s...